Dear members and colleagues,
please find below a message from Richard Bergstroem , EFPIA DG with respect to the various elements of the Clinical Data sharing debate , the assignment of responsibilities (including work with US PhRMA colleagues) and next steps
A. Forthcoming industry commitment, incl advocacy:
There will be a series of meetings in Brussels, organised jointly by PhRMA and EFPIA, in the week of August 26 to advance these strands.
Whereas the press release was quite balanced, the detailed proposal raises concerns:
A detailed response will be prepared by a joint EFPIA-PhRMA team. The work will be led by [Redacted], Lilly, [Redacted]. From the EFPIA side the EFPIA TWG chairs (Rules of engagement, Patient confidentiality, good analysis practice, CT data format, legal aspects) will be part of the drafting group:
The EFPIA PACT(Public Affairs on Clinical Trials) is responsible and will work closely with national associations and Brussels staff.